274 related articles for article (PubMed ID: 25391483)
1. Semen enhances HIV infectivity and impairs the antiviral efficacy of microbicides.
Zirafi O; Kim KA; Roan NR; Kluge SF; Müller JA; Jiang S; Mayer B; Greene WC; Kirchhoff F; Münch J
Sci Transl Med; 2014 Nov; 6(262):262ra157. PubMed ID: 25391483
[TBL] [Abstract][Full Text] [Related]
2. Semen enhances transmitted/founder HIV-1 infection and only marginally reduces antiviral activity of broadly neutralizing antibodies.
von Maltitz P; Wettstein L; Weil T; Schommers P; Klein F; Münch J
J Virol; 2024 Apr; 98(4):e0119023. PubMed ID: 38501840
[TBL] [Abstract][Full Text] [Related]
3. Polyanionic candidate microbicides accelerate the formation of semen-derived amyloid fibrils to enhance HIV-1 infection.
Tan S; Lu L; Li L; Liu J; Oksov Y; Lu H; Jiang S; Liu S
PLoS One; 2013; 8(3):e59777. PubMed ID: 23544097
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of HIV antiviral polyanionic carbosilane dendrimer G2-S16 in the presence of semen.
Ceña-Diez R; García-Broncano P; de la Mata FJ; Gómez R; Muñoz-Fernández MÁ
Int J Nanomedicine; 2016; 11():2443-50. PubMed ID: 27313457
[TBL] [Abstract][Full Text] [Related]
5. Clinical development of microbicides for the prevention of HIV infection.
D'Cruz OJ; Uckun FM
Curr Pharm Des; 2004; 10(3):315-36. PubMed ID: 14754390
[TBL] [Abstract][Full Text] [Related]
6. The High Content of Fructose in Human Semen Competitively Inhibits Broad and Potent Antivirals That Target High-Mannose Glycans.
Johnson J; Flores MG; Rosa J; Han C; Salvi AM; DeMali KA; Jagnow JR; Sparks A; Haim H
J Virol; 2020 Apr; 94(9):. PubMed ID: 32102878
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of carbosilane dendrimers with an antiretroviral combination against HIV-1 in the presence of semen-derived enhancer of viral infection.
García-Broncano P; Ceña-Diez R; de la Mata FJ; Gómez R; Resino S; Muñoz-Fernández MÁ
Eur J Pharmacol; 2017 Sep; 811():155-163. PubMed ID: 28577966
[TBL] [Abstract][Full Text] [Related]
8. A molecular tweezer antagonizes seminal amyloids and HIV infection.
Lump E; Castellano LM; Meier C; Seeliger J; Erwin N; Sperlich B; Stürzel CM; Usmani S; Hammond RM; von Einem J; Gerold G; Kreppel F; Bravo-Rodriguez K; Pietschmann T; Holmes VM; Palesch D; Zirafi O; Weissman D; Sowislok A; Wettig B; Heid C; Kirchhoff F; Weil T; Klärner FG; Schrader T; Bitan G; Sanchez-Garcia E; Winter R; Shorter J; Münch J
Elife; 2015 Aug; 4():. PubMed ID: 26284498
[TBL] [Abstract][Full Text] [Related]
9. Role of seminal plasma in the anti-HIV-1 activity of candidate microbicides.
Neurath AR; Strick N; Li YY
BMC Infect Dis; 2006 Oct; 6():150. PubMed ID: 17042959
[TBL] [Abstract][Full Text] [Related]
10. The anti-parasitic drug suramin potently inhibits formation of seminal amyloid fibrils and their interaction with HIV-1.
Tan S; Li JQ; Cheng H; Li Z; Lan Y; Zhang TT; Yang ZC; Li W; Qi T; Qiu YR; Chen Z; Li L; Liu SW
J Biol Chem; 2019 Sep; 294(37):13740-13754. PubMed ID: 31346035
[TBL] [Abstract][Full Text] [Related]
11. The main green tea polyphenol epigallocatechin-3-gallate counteracts semen-mediated enhancement of HIV infection.
Hauber I; Hohenberg H; Holstermann B; Hunstein W; Hauber J
Proc Natl Acad Sci U S A; 2009 Jun; 106(22):9033-8. PubMed ID: 19451623
[TBL] [Abstract][Full Text] [Related]
12. Mucosal human defensins 5 and 6 antagonize the anti-HIV activity of candidate polyanion microbicides.
Ding J; Rapista A; Teleshova N; Lu W; Klotman ME; Chang TL
J Innate Immun; 2011; 3(2):208-12. PubMed ID: 21160168
[TBL] [Abstract][Full Text] [Related]
13. Comparative evaluation of virus transmission inhibition by dual-acting pyrimidinedione microbicides using the microbicide transmission and sterilization assay.
Watson KM; Buckheit CE; Buckheit RW
Antimicrob Agents Chemother; 2008 Aug; 52(8):2787-96. PubMed ID: 18559653
[TBL] [Abstract][Full Text] [Related]
14. Mechanistic Studies of Viral Entry: An Overview of Dendrimer-Based Microbicides As Entry Inhibitors Against Both HIV and HSV-2 Overlapped Infections.
Sepúlveda-Crespo D; Ceña-Díez R; Jiménez JL; Ángeles Muñoz-Fernández M
Med Res Rev; 2017 Jan; 37(1):149-179. PubMed ID: 27518199
[TBL] [Abstract][Full Text] [Related]
15. Baseline and time-updated factors in preclinical development of anionic dendrimers as successful anti-HIV-1 vaginal microbicides.
Rodríguez-Izquierdo I; Sepúlveda-Crespo D; Lasso JM; Resino S; Muñoz-Fernández MÁ
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 May; 14(3):e1774. PubMed ID: 35018739
[TBL] [Abstract][Full Text] [Related]
16. Enhanced activity of carbosilane dendrimers against HIV when combined with reverse transcriptase inhibitor drugs: searching for more potent microbicides.
Vacas-Córdoba E; Galán M; de la Mata FJ; Gómez R; Pion M; Muñoz-Fernández MÁ
Int J Nanomedicine; 2014; 9():3591-600. PubMed ID: 25114528
[TBL] [Abstract][Full Text] [Related]
17. Development of sulphated and naphthylsulphonated carbosilane dendrimers as topical microbicides to prevent HIV-1 sexual transmission.
Vacas Córdoba E; Arnaiz E; Relloso M; Sánchez-Torres C; García F; Pérez-Álvarez L; Gómez R; de la Mata FJ; Pion M; Muñoz-Fernández MÁ
AIDS; 2013 May; 27(8):1219-29. PubMed ID: 23925376
[TBL] [Abstract][Full Text] [Related]
18. Polyanionic carbosilane dendrimer-conjugated antiviral drugs as efficient microbicides: Recent trends and developments in HIV treatment/therapy.
Sepúlveda-Crespo D; Gómez R; De La Mata FJ; Jiménez JL; Muñoz-Fernández MÁ
Nanomedicine; 2015 Aug; 11(6):1481-98. PubMed ID: 25835558
[TBL] [Abstract][Full Text] [Related]
19. Microbicides: a new hope for HIV prevention.
; Gupta SK
Indian J Med Res; 2011 Dec; 134(6):939-49. PubMed ID: 22310826
[TBL] [Abstract][Full Text] [Related]
20. Synergistic activity of carbosilane dendrimers in combination with maraviroc against HIV in vitro.
Córdoba EV; Arnáiz E; De La Mata FJ; Gómez R; Leal M; Pion M; Muñoz-Fernández MA
AIDS; 2013 Aug; 27(13):2053-8. PubMed ID: 23612005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
